Breaking News Instant updates and real-time market news.

AXSM

Axsome Therapeutics

$79.65

32.86 (70.23%)

07:24
12/17/19
12/17
07:24
12/17/19
07:24

Axsome Therapeutics added to Nasdaq Biotechnology Index

Axsome Therapeutics has been selected for addition to the NASDAQ Biotechnology Index, as part of the annual index evaluation. The Company's addition to the index will become effective prior to the market open on Monday, December 23, 2019.

AXSM Axsome Therapeutics
$79.65

32.86 (70.23%)

12/16/19
GUGG
12/16/19
NO CHANGE
Target $158
GUGG
Buy
Axsome Therapeutics price target raised to $158 from $65 at Guggenheim
Guggenheim analyst Yatin Suneja raised Buy rated Axsome Therapeutics' price target to $158 from $65 after the company announced positive topline Phase 3 GEMINI data for AXS-05 in major depressive disorder.
12/16/19
PIPR
12/16/19
NO CHANGE
Target $125
PIPR
Overweight
Sage drug still differentiated despite positive Axsome data, says Piper Jaffray
Piper Jaffray analyst Danielle Brill says nothing has really changed with Sage Therapeutics' (SAGE) SAGE-217 after Axsome Therapeutics (AXSM) announced positive Phase 3 data for AXS-05 in major depressive disorder. Though Axsome's data are "impressive," SAGE-217's rapid onset of action is differentiated, and ultimately there is "plenty of room" for both agents in the space, Brill tells investors in a research note. Further, the analyst adds that SAGE-217's profile is "uniquely suited" for post-partum depression, and that see expects no impact from Axsome in that setting/ Brill remains optimistic that Sage will be successful in future trials and she reiterates an Overweight rating on the shares with a $125 price target. The stock closed Monday down 4% to $70.00.
12/16/19
PIPR
12/16/19
NO CHANGE
Target $125
PIPR
Overweight
Sage drug still differentiated despite positive Axsome data, says Piper Jaffray
Piper Jaffray analyst Danielle Brill says nothing has really changed with Sage Therapeutics' (SAGE) SAGE-217 after Axsome Therapeutics (AXSM) announced positive Phase 3 data for AXS-05 in major depressive disorder. Though Axsome's data are "impressive," SAGE-217's rapid onset of action is differentiated, and ultimately there is "plenty of room" for both agents in the space, Brill tells investors in a research note. Further, the analyst adds that SAGE-217's profile is "uniquely suited" for post-partum depression, and that see expects no impact from Axsome in that setting/ Brill remains optimistic that Sage will be successful in future trials and she reiterates an Overweight rating on the shares with a $125 price target. The stock closed Monday down 4% to $70.00.
12/17/19
HCWC
12/17/19
NO CHANGE
Target $170
HCWC
Buy
Axsome Therapeutics price target raised to $170 from $30 at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju raised his price target for Axsome Therapeutics to $170 from $30 after the company reported that the GEMINI Phase 3 trial of its lead candidate AXS-05 in major depressive disorder met its primary endpoint. The shares closed Monday up 71%, or $33.01, to $79.80. The analyst increased his probability of approval for AXS-05 to 80% from 50% and adding penetration in the major depressive disorder setting to his market forecasts. This, in addition to the inclusion of AXS-12 in a sum-of-the-parts valuation assessment, boosts the 12-month projected valuation of the company to $7.7B from the previous $1.4B, Selvaraju tells investors in a research note. The analyst reiterates a Buy rating on Axsome Therapeutics.

TODAY'S FREE FLY STORIES

MDLZ

Mondelez

$55.47

-0.1 (-0.18%)

16:16
01/22/20
01/22
16:16
01/22/20
16:16
Initiation
Mondelez initiated  »

Mondelez initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 17

    Feb

PLXS

Plexus

$79.66

1.45 (1.85%)

16:16
01/22/20
01/22
16:16
01/22/20
16:16
Earnings
Plexus reports Q1 EPS $1.00, consensus 93c »

Reports Q1 revenue $852M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 12

    Feb

  • 26

    Mar

CPB

Campbell Soup

$48.56

-0.01 (-0.02%)

16:16
01/22/20
01/22
16:16
01/22/20
16:16
Initiation
Campbell Soup initiated  »

Campbell Soup initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MKC

McCormick

$172.51

1.31 (0.77%)

16:16
01/22/20
01/22
16:16
01/22/20
16:16
Initiation
McCormick initiated  »

McCormick initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 17

    Feb

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
01/22/20
01/22
16:16
01/22/20
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IO

ION Geophysical

$6.05

-0.02 (-0.33%)

16:16
01/22/20
01/22
16:16
01/22/20
16:16
Hot Stocks
ION Geophysical signs agreements for 2D, 3D programs offshore Colombia »

ION Geophysical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNS

Cohen & Steers

$67.03

1.11 (1.68%)

16:15
01/22/20
01/22
16:15
01/22/20
16:15
Earnings
Cohen & Steers reports Q4 adjusted EPS 74c, consensus 68c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 26

    Feb

ACRE

Ares Commercial

$16.55

0.09 (0.55%)

16:15
01/22/20
01/22
16:15
01/22/20
16:15
Syndicate
Ares Commercial files to sell 4M shares of common stock »

Wells Fargo Securities,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTXS

Citrix

$119.16

1.37 (1.16%)

16:15
01/22/20
01/22
16:15
01/22/20
16:15
Earnings
Citrix sees FY20 EPS $5.35-$5.55, consensus $5.43 »

Sees FY20 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

PACQ

Pure Acquisition Corp.

$10.38

(0.00%)

16:15
01/22/20
01/22
16:15
01/22/20
16:15
Hot Stocks
Pure says combined HighPeak sssets achieved projection of 12,000Boe/d »

Pure Acquisition its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTXS

Citrix

$119.11

1.32 (1.12%)

16:14
01/22/20
01/22
16:14
01/22/20
16:14
Earnings
Citrix sees Q1 EPS $1.15-$1.20, consensus $1.23 »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

CAG

Conagra Brands

$32.31

-0.45 (-1.37%)

16:14
01/22/20
01/22
16:14
01/22/20
16:14
Initiation
Conagra Brands initiated  »

Conagra Brands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Feb

BFST

Business First Bancshares

$24.66

0.11 (0.45%)

16:14
01/22/20
01/22
16:14
01/22/20
16:14
Hot Stocks
Business First Bancshares, Pedestal Bancshares announce $211.2M merger »

Business First Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTXS

Citrix

$119.02

1.23 (1.04%)

16:13
01/22/20
01/22
16:13
01/22/20
16:13
Hot Stocks
Citrix reports Q4 ARR up 41% from last year to $743M »

Q4 subscription ARR was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

STL

Sterling Bancorp

$20.50

-0.09 (-0.44%)

16:12
01/22/20
01/22
16:12
01/22/20
16:12
Earnings
Sterling Bancorp reports Q4 EPS 54c, consensus 53c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

CTXS

Citrix

$119.28

1.49 (1.26%)

16:12
01/22/20
01/22
16:12
01/22/20
16:12
Hot Stocks
Citrix board increases stock buyback by $1B »

On January 21, 2020…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

TWNK

Hostess Brands

$13.81

-0.08 (-0.58%)

16:12
01/22/20
01/22
16:12
01/22/20
16:12
Initiation
Hostess Brands initiated  »

Hostess Brands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

RLI

RLI Corp.

$93.98

0.38 (0.41%)

16:11
01/22/20
01/22
16:11
01/22/20
16:11
Earnings
RLI reports Q4 ops EPS 63c, consensus 59c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 26

    Feb

MGY

Magnolia Oil & Gas

$11.89

-0.27 (-2.22%)

16:11
01/22/20
01/22
16:11
01/22/20
16:11
Downgrade
Magnolia Oil & Gas rating change  »

Magnolia Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

AVNW

Aviat Networks

$14.43

-0.18 (-1.23%)

16:11
01/22/20
01/22
16:11
01/22/20
16:11
Earnings
Aviat Networks lowers Q2 and FY20 guidance due to cyberattack »

Aviat Networks expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCRH

QCR Holdings

$41.82

0.03 (0.07%)

16:10
01/22/20
01/22
16:10
01/22/20
16:10
Earnings
QCR Holdings reports Q4 EPS 96c, consensus 87c »

Q4 net interest income…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

CTXS

Citrix

$119.30

1.51 (1.28%)

16:10
01/22/20
01/22
16:10
01/22/20
16:10
Earnings
Citrix reports Q4 adjusted EPS $1.71, consensus $1.68 »

Reports Q4 revenue $810M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

CPE

Callon Petroleum

$3.53

-0.185 (-4.99%)

16:10
01/22/20
01/22
16:10
01/22/20
16:10
Downgrade
Callon Petroleum rating change  »

Callon Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BFST

Business First Bancshares

$24.66

0.11 (0.45%)

16:09
01/22/20
01/22
16:09
01/22/20
16:09
Earnings
Business First Bancshares reports Q4 core EPS 45c, consensus 47c »

Reports Q4 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOG

Extraction Oil & Gas

$1.68

-0.045 (-2.61%)

16:09
01/22/20
01/22
16:09
01/22/20
16:09
Downgrade
Extraction Oil & Gas rating change  »

Extraction Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.